COVID 19 RT-qPCR
- UID
- MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528
- Device class
- Class C
- Brand name
- ProPCR
- License holder
- Promea Therapeutics Private Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- It is used to detect target gene amplification through gene specific primers and probes by using Taq Man Chemistry Method
COVID 19 RT-qPCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528. This device is marketed under the brand name ProPCR. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.